Breaking Down Silos: The Financial Toxicity Tumor Board as a Model for Addressing Treatment-Related Financial Burden

Author:
Minal R. Patel Department of Health Behavior & Health Equity, University of Michigan School of Public Health, Ann Arbor, MI

Search for other papers by Minal R. Patel in
Current site
Google Scholar
PubMed Close
 PhD, MPH
Volume/Issue:
Volume 23: Issue 5
Online Publication Date:
May 2025
DOI:
https://doi.org/10.6004/jnccn.2025.7047
Restricted access

Disclosures: Dr. Patel has disclosed having no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors.

Correspondence: Minal R. Patel, PhD, MPH, Department of Health Behavior & Health Equity, University of Michigan School of Public Health, 1415 Washington Heights, SPH 1, Room 3810, Ann Arbor, MI 48109-2029. Email: minalrp@umich.edu
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
  • 1.

    Zafar SY, Abernethy AP. Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park) 2013;27:80–81, 149.

  • 2.

    Knight TG, Hensel C, Blackley K, et al. The Financial Toxicity Tumor Board: 5-year update on practice and a guide to implementation. J Natl Compr Canc Netw 2025;23:164–168.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Raghavan D, Keith NA, Warden HR, et al. Levine Cancer Institute financial toxicity tumor board: a potential solution to an emerging problem. JCO Oncol Pract 2021;17:e1433–1439.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Wheeler SB, Thom B, Waters AR, Shankaran V. Interventions to address cancer-related financial hardship: a scoping review and call to action. JCO Oncol Pract 2025;21:29–40.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Scanlon DP, Shi Y, Burns LR. It’s the healthcare production function dummy… (and still the prices stupid)! Health Serv Res 2025;25:e14611.

  • 6.

    Peppercorn J, Gelin M, Masteralexis TE, et al. Screening for financial toxicity in oncology research and practice: a narrative review. JCO Oncol Pract 2025;21:5–11.

  • 7.

    Pangestu S, Rencz F. Comprehensive score for financial toxicity and health-related quality of life in patients with cancer and survivors: a systematic review and meta-analysis. Value Health 2023;26:300–316.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Jazowski SA, Nayak RK, Dusetzina SB. The high costs of anticancer therapies in the USA: challenges, opportunities and progress. Nat Rev Clin Oncol 2024;21:888–899.

    • PubMed
    • Search Google Scholar
    • Export Citation
Copyright:
Copyright © 2025 by the National Comprehensive Cancer Network 2025
Page Numbers:
2
Article Category:
Research Article
Print Publication Date:
01 May 2025
Online Publication Date:
May 2025

Metrics